Search research articles
Contact Us
Filters
Showing results (221-230 of 241) with videos related to
Page
of 25
Sort By:
BMC Cancer
|
February 6, 2025
Study protocol of the METAPANC trial - intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trial
Michael Ghadimi, Uwe Pelzer, Marc G Besselink, et al.
JAMA Surgery
|
June 7, 2018
Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial
Julia Kitz, Emmanouil Fokas, Tim Beissbarth, et al.
The Lancet. Oncology
|
July 20, 2015
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial
Claus Rödel, Ullrich Graeven, Rainer Fietkau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 13, 2025
Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial
Rainer Fietkau, Michael Ghadimi, Robert Grützmann, et al.
Surgery
|
July 17, 2024
International differences in the selection and outcome of minimally invasive and open distal pancreatectomy: A transatlantic analysis
Karin U Johansen, Simone Augustinus, Ulrich F Wellner, et al.
Genome Medicine
|
May 26, 2021
Hard wiring of normal tissue-specific chromosome-wide gene expression levels is an additional factor driving cancer type-specific aneuploidies
Sushant Patkar, Kerstin Heselmeyer-Haddad, Noam Auslander, et al.
JAMA Oncology
|
November 18, 2021
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial
Emmanouil Fokas, Anke Schlenska-Lange, Bülent Polat, et al.
Cancers
|
February 11, 2023
Consensus Statement on the Use of Near-Infrared Fluorescence Imaging during Pancreatic Cancer Surgery Based on a Delphi Study: Surgeons' Perspectives on Current Use and Future Recommendations
Lysanne D A N de Muynck, Kevin P White, Adnan Alseidi, et al.
Cancer Cell
|
February 5, 2022
Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer
Adele M Nicolas, Marina Pesic, Esther Engel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2019
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
Emmanouil Fokas, Michael Allgäuer, Bülent Polat, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 241) with videos related to
Sort By:
Page
of 25
BMC Cancer
|
February 6, 2025
Study protocol of the METAPANC trial - intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trial
Michael Ghadimi, Uwe Pelzer, Marc G Besselink, et al.
JAMA Surgery
|
June 7, 2018
Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial
Julia Kitz, Emmanouil Fokas, Tim Beissbarth, et al.
The Lancet. Oncology
|
July 20, 2015
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial
Claus Rödel, Ullrich Graeven, Rainer Fietkau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 13, 2025
Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial
Rainer Fietkau, Michael Ghadimi, Robert Grützmann, et al.
Surgery
|
July 17, 2024
International differences in the selection and outcome of minimally invasive and open distal pancreatectomy: A transatlantic analysis
Karin U Johansen, Simone Augustinus, Ulrich F Wellner, et al.
Genome Medicine
|
May 26, 2021
Hard wiring of normal tissue-specific chromosome-wide gene expression levels is an additional factor driving cancer type-specific aneuploidies
Sushant Patkar, Kerstin Heselmeyer-Haddad, Noam Auslander, et al.
JAMA Oncology
|
November 18, 2021
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial
Emmanouil Fokas, Anke Schlenska-Lange, Bülent Polat, et al.
Cancers
|
February 11, 2023
Consensus Statement on the Use of Near-Infrared Fluorescence Imaging during Pancreatic Cancer Surgery Based on a Delphi Study: Surgeons' Perspectives on Current Use and Future Recommendations
Lysanne D A N de Muynck, Kevin P White, Adnan Alseidi, et al.
Cancer Cell
|
February 5, 2022
Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer
Adele M Nicolas, Marina Pesic, Esther Engel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2019
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
Emmanouil Fokas, Michael Allgäuer, Bülent Polat, et al.
Page
of 25